Lila Sciences, an AI-driven company aiming to build ‘scientific superintelligence,’ is reportedly closing a Series A funding round exceeding $300 million. The oversubscribed mega-round will support the development of autonomous scientific discovery platforms. This places Lila Sciences among the highest funding raises in AI-focused biotech startups, signaling strong investor confidence in leveraging AI for accelerated research innovation.